AU4743196A - Non-traumatic administration of gene delivery vehicles - Google Patents
Non-traumatic administration of gene delivery vehiclesInfo
- Publication number
- AU4743196A AU4743196A AU47431/96A AU4743196A AU4743196A AU 4743196 A AU4743196 A AU 4743196A AU 47431/96 A AU47431/96 A AU 47431/96A AU 4743196 A AU4743196 A AU 4743196A AU 4743196 A AU4743196 A AU 4743196A
- Authority
- AU
- Australia
- Prior art keywords
- gene delivery
- delivery vehicles
- traumatic administration
- traumatic
- administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
- A61K38/37—Factors VIII
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/45—Transferases (2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
- C12N2740/13041—Use of virus, viral particle or viral elements as a vector
- C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/44—Vectors comprising a special translation-regulating system being a specific part of the splice mechanism, e.g. donor, acceptor
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Virology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36678894A | 1994-12-30 | 1994-12-30 | |
US366788 | 1994-12-30 | ||
PCT/US1995/016967 WO1996020732A2 (en) | 1994-12-30 | 1995-12-20 | Non-traumatic administration of gene delivery vehicles |
Publications (1)
Publication Number | Publication Date |
---|---|
AU4743196A true AU4743196A (en) | 1996-07-24 |
Family
ID=23444505
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU47431/96A Abandoned AU4743196A (en) | 1994-12-30 | 1995-12-20 | Non-traumatic administration of gene delivery vehicles |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0800403A2 (en) |
JP (1) | JPH10512243A (en) |
AU (1) | AU4743196A (en) |
WO (1) | WO1996020732A2 (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5695993A (en) | 1994-08-12 | 1997-12-09 | Oklahoma Medical Research Foundation | Cloning and regulation of an endothelial cell protein C/activated protein C receptor |
ZA973642B (en) | 1996-04-26 | 1997-11-25 | Merck & Co Inc | DNA vaccine formulations. |
US5945100A (en) * | 1996-07-31 | 1999-08-31 | Fbp Corporation | Tumor delivery vehicles |
WO1998008539A1 (en) * | 1996-08-26 | 1998-03-05 | Chiron Corporation | Postinfection human immunodeficiency virus (hiv) vaccination therapy |
EP2298900A1 (en) * | 1996-09-17 | 2011-03-23 | Novartis Vaccines and Diagnostics, Inc. | Compositions and methods for treating intracellular diseases |
US6096303A (en) * | 1997-07-31 | 2000-08-01 | Medical College Of Georgia Research Institute, Inc. | Method to enhance treatment of cystic tumors |
EP0967288A1 (en) * | 1998-06-16 | 1999-12-29 | Hoechst Marion Roussel Deutschland GmbH | Transfection system for the transfer of nucleic acids into cells |
AU1029099A (en) * | 1997-10-10 | 1999-05-03 | Aventis Pharma Deutschland Gmbh | Transfection system for the transfer of nucleic acids into cells |
EP0908521A1 (en) * | 1997-10-10 | 1999-04-14 | Hoechst Marion Roussel Deutschland GmbH | Transfection system for the transfer of nucleic acids into cells |
AU1922999A (en) * | 1997-12-16 | 1999-07-05 | Baylor College Of Medicine | Needle-free injection of formulated nucleic acid molecules |
US6953568B1 (en) | 1998-08-25 | 2005-10-11 | Oklahoma Medical Research Foundation | Targeting of molecules to large vessel endothelium using EPCR |
JP2003523721A (en) | 1998-12-31 | 2003-08-12 | カイロン コーポレイション | Polynucleotides encoding antigenic HIVC-type polypeptides, polypeptides, and uses thereof |
DE10010959A1 (en) * | 2000-03-06 | 2001-09-20 | Eppendorf Geraetebau Netheler | Transferring material through cell membranes, useful e.g. in genetic engineering or hydride production, using aqueous solution containing trehalose, increases cell survival |
WO2002063026A1 (en) * | 2001-02-08 | 2002-08-15 | Geneporter, Inc. | Complexes and components thereof for introducing polynucleotides into eukaryotic cells |
CA2452015C (en) | 2001-07-05 | 2012-07-03 | Chiron Corporation | Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0648271T3 (en) * | 1991-08-20 | 2003-07-21 | Us Gov Health & Human Serv | Adenovirus-mediated transmission of gastrointestinal tract genes |
DE69333057T2 (en) * | 1992-08-07 | 2004-07-08 | Wyeth | Recombinant adenovirus vaccines |
WO1994023582A1 (en) * | 1993-04-08 | 1994-10-27 | Genetic Therapy, Inc. | Adenoviral vectors including dna encoding lung surfactant protein |
-
1995
- 1995-12-20 EP EP95944671A patent/EP0800403A2/en not_active Withdrawn
- 1995-12-20 JP JP8521148A patent/JPH10512243A/en not_active Ceased
- 1995-12-20 WO PCT/US1995/016967 patent/WO1996020732A2/en not_active Application Discontinuation
- 1995-12-20 AU AU47431/96A patent/AU4743196A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP0800403A2 (en) | 1997-10-15 |
WO1996020732A3 (en) | 1996-12-12 |
JPH10512243A (en) | 1998-11-24 |
WO1996020732A2 (en) | 1996-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2946295A (en) | Targeted gene delivery system | |
AU7676894A (en) | Convection-enhanced drug delivery | |
AU4989993A (en) | Drug delivery system | |
AU3739697A (en) | Gene delivery system | |
AU9676198A (en) | Drug delivery and gene therapy delivery system | |
AU2543795A (en) | Methods of in vivo gene delivery | |
AU664807B2 (en) | Drug delivery system | |
AU3050892A (en) | Delivery system | |
AU2911695A (en) | Inplantable drug delivery pump | |
AU7493398A (en) | Pulsatile drug delivery system | |
AU7401698A (en) | Decoupled liquid delivery system | |
AU6295394A (en) | Peptide linkers for improved oligonucleotide delivery | |
AU5153296A (en) | Vectors for gene delivery | |
AU4370593A (en) | Tissue-specific implantable therapeutic agent delivery system | |
AU3560495A (en) | Medicament inhaler | |
AU3204995A (en) | Closed drug delivery system | |
AU3229095A (en) | Particle delivery | |
AU4787697A (en) | Therapeutic gene | |
AU2324497A (en) | Delivery of nucleic acids by porphyrins | |
AU6982598A (en) | Cassette and delivery system | |
AU1403199A (en) | Local delivery of therapeutic agents | |
AUPN741696A0 (en) | Delivery of nucleic acids ii | |
AU2548697A (en) | Local delivery of chemotherapeutic agents for treatment of periodontal disease | |
AU4743196A (en) | Non-traumatic administration of gene delivery vehicles | |
AU7840994A (en) | Active substance delivery system |